Business Context and Reporting Period
Registrant: Venus Acquisition Corporation, a Cayman Islands special purpose acquisition company (SPAC); the filing metadata references MicroAlgo Inc., the proposed post-combination name. The unaudited Form 10-Q covers the three months ended March 31, 2022 and was filed May 13, 2022.
The company has no operating business or revenue and was formed to complete a business combination. On June 10, 2021, it entered into a merger agreement with VIYI Algorithm Inc. Under the proposed transaction, VIYI shareholders would receive approximately 39.6 million shares valued at $400 million, and VIYI would become a wholly owned subsidiary. The company intends to change its name to MicroAlgo Inc. upon closing.
Financial Position and Results
| Metric | March 31, 2022 / Q1 2022 | Comparable period or prior year-end |
|---|---|---|
| Revenue | None; no operating revenue | None |
| Net loss | $173,823 | $88,323 in Q1 2021 |
| Operating expenses | $167,638 | $78,705 in Q1 2021 |
| Interest income | $3,815 | $382 in Q1 2021 |
| Net cash used in operating activities | $173,421 | $198,502 in Q1 2021 |
| Cash outside trust | $28,668 | $32,090 at December 31, 2021 |
| Trust account | $46.780 million | $46.469 million at December 31, 2021 |
| Working capital | Deficit of $892,476 | Not clearly provided for the comparable period |
| Total liabilities | $2.491 million | $2.027 million at December 31, 2021 |
The company reported no meaningful operating margin because it has no revenue; its net loss principally reflects general and administrative expenses and the non-cash change in fair value of warrant liabilities. No income tax expense was recorded. Basic and diluted loss per share was $0.08 for non-redeemable shares and $0.01 for redeemable shares.
Trust assets consisted of U.S. Treasury securities. The company had 4.6 million public shares subject to possible redemption, recorded as temporary equity at approximately $10.17 per share. It also had $1.15 million of deferred underwriting compensation, $420,000 of warrant liabilities, $543,420 of advances from the sponsor, and $306,666 of related-party notes payable at March 31, 2022.
Material Changes Versus Prior Comparable Period
- Net loss increased to $173,823 from $88,323, while formation and general and administrative expenses increased to $167,638 from $78,705.
- Operating cash usage improved to $173,421 from $198,502, primarily because the prior-year period included higher working-capital uses.
- Cash outside the trust declined by $3,422 during the quarter, while trust assets increased by approximately $310,481 from interest income.
- The company recorded a $310,481 accretion of redeemable shares to redemption value, compared with $3.633 million in Q1 2021.
- Liabilities increased by approximately $464,165 from December 31, 2021, primarily due to sponsor advances and related-party notes payable.
- Management reported material weaknesses in internal control over financial reporting related to the accounting classification of warrants and redeemable ordinary shares. The company restated prior financial statements and initiated a remediation plan.
Outlook, Risks, Contingencies, and Unusual Items
- The merger agreement was amended in January 2022 to extend the outside termination date to June 30, 2022, terminate the original backstop agreement, establish a new backstop with WiMi Hologram Cloud Inc., and acknowledge potentially required Chinese governmental approvals.
- WiMi agreed to purchase up to $15 million of shares in connection with redemptions or a private placement, subject to the agreement’s terms. Completion remains subject to shareholder approval, minimum net tangible assets, regulatory approvals, and other customary conditions.
- The company extended its business-combination deadline from February 11 to March 11, April 11, and May 11, 2022 by depositing $153,333 into the trust account for each extension. The April 11 extension occurred after quarter-end.
- If no business combination is completed within the permitted combination period, the company must cease operations, redeem the public shares using the trust account, and liquidate. Public rights and warrants could expire worthless.
- Management states that the company has substantial doubt about its ability to continue as a going concern for one year if a business combination is not completed. It depends on sponsor or related-party financing to fund working capital and transaction costs; additional financing is not assured.
- The company had no long-term debt or off-balance-sheet financing arrangements, but sponsor loans and advances are payable upon completion of a business combination or otherwise subject to their contractual terms. The sponsor’s February 10, 2022 promissory note had a principal amount of $650,000 and bears no interest.
- COVID-19 and changes in Chinese laws or governmental approval requirements could adversely affect the proposed transaction, although the specific financial impact was not determinable at quarter-end.
- No legal proceedings or unregistered equity issuances were reported during the quarter.
Most Important Facts for Investors to Verify
- Whether the proposed VIYI transaction closed, was further amended, or terminated after the May 11, 2022 deadline and before any subsequent filing.
- The status of SEC review of the Form S-4/proxy statement, shareholder approval, required Chinese regulatory approvals, and the WiMi backstop.
- The company’s actual redemption levels, post-combination capitalization, dilution from rights and warrants, and final consideration issued to VIYI shareholders.
- Whether the disclosed material weaknesses in financial reporting controls were remediated and whether any further restatements were required.
- The availability and terms of sponsor financing, the $1.15 million deferred underwriting fee, and other claims against funds outside the trust account.
- The filing identifies the registrant as Venus Acquisition Corporation; investors should confirm the effective date and details of any subsequent name change to MicroAlgo Inc.